Literature DB >> 8859084

Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.

P Mitchell1, W Smith, A Chang.   

Abstract

OBJECTIVE: To determine the prevalence and associations of retinal vein occlusion (RVO) in a defined older Australian population.
DESIGN: Participants (N = 3654; age, > or = 49 years), representing 88% of the permanent residents from an area west of Sydney, Australia, underwent a detailed eye examination, including stereophotography (Zeiss). The diagnosis of RVO was made clinically and from photographic grading.
RESULTS: Signs of RVO were found in 59 participants (1.6%; 95% confidence interval, 1.3-1.9). The prevalence for each age-specific participant was as follows: 0.7%, younger than 60 years; 1.2%, 60 to 69 years; 2.1%, 70 to 79 years; and 4.6%, 80 years or older. There was no significant sex difference in prevalence. Branch RVO was observed in 41 subjects (69.5%); of this number, 10 subjects had branch RVO outside the vascular arcade or in the nasal fundus and 3 subjects developed new vessels. Hemispheric RVO was found in 3 subjects (5.1%), and central RVO was observed in 15 (25%); RVO was bilateral in 3 subjects (5.1%). Visual acuity was affected most in the people with central RVO, with a visual acuity of 20/200 or less in 60% compared with 14% among the people with branch RVO. Retinal vein occlusion was the fifth most frequent cause of unilateral blindness in this population. Significant associations with RVO were found with glaucoma, hypertension, stroke, and angina.
CONCLUSIONS: This study emphasizes RVO as an important cause of unilateral visual loss in an older population. The proportion of the 3 vein occlusion sites shows some differences from those of clinic-based reports and suggests a likely selection bias in previous clinic studies.

Entities:  

Mesh:

Year:  1996        PMID: 8859084     DOI: 10.1001/archopht.1996.01100140443012

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  138 in total

Review 1.  Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.

Authors:  M Paques; J N Vallée; D Herbreteau; A Aymart; P Y Santiago; F Campinchi-Tardy; D Payen; J J Merlan; A Gaudric; P Massin
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

3.  Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.

Authors:  M Cahill; M Karabatzaki; R Meleady; H Refsum; P Ueland; D Shields; D Mooney; I Graham
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 4.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  Ocular and systemic causes of retinopathy in patients without diabetes mellitus.

Authors:  Jayant Venkatramani; Paul Mitchell
Journal:  BMJ       Date:  2004-03-13

Review 6.  Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors:  Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-27       Impact factor: 3.117

7.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

8.  Pulse-wave analysis of optic nerve head circulation is significantly correlated with brachial-ankle pulse-wave velocity, carotid intima-media thickness, and age.

Authors:  Tomoaki Shiba; Mao Takahashi; Yuichi Hori; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

9.  Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.

Authors:  Jérôme Charbonnel; Agnès Glacet-Bernard; Jean-François Korobelnik; Emilienne Nyouma-Moune; Constantin J Pournaras; Joseph Colin; Gabriel Coscas; Gisèle Soubrane
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

10.  Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment.

Authors:  Chan Hee Moon; Sang Il Ahn; Young-Hoon Ohn; Hyung Woo Kwak; Tae Kwann Park
Journal:  Doc Ophthalmol       Date:  2013-03-15       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.